CNMD Stock Analysis: Buy, Sell, or Hold?
CNMD - CONMED Corporation
$46.30
-0.68 (-1.45%)
▼
5d:
+8.48%
30d:
+41.33%
90d:
+26.3%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When CNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CNMD shows positive signals but monitor for confirmation. Market pricing in 6.3% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: CNMD shows positive signals but monitor for confirmation. Market pricing in 6.3% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$52.64
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$32.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNMD is currently trading at $46.30, which is considered extended relative to its 30-day fair value range of $35.03 to $44.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.8) compared to its historical average (8.2). At these levels, the market is pricing in 6.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNMD is in a uptrend. Immediate support is located at $40.98, while resistance sits at $49.00.
Market Sentiment: CNMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $39.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CNMD is in a uptrend. Immediate support is located at $40.98, while resistance sits at $49.00.
Market Sentiment: CNMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $39.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$35.03 -
$44.12
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 15.8% above Wall St target ($39.00)
- NEUTRAL: PE elevated vs history but 6.3% growth expectation is conservative given 137% recent growth
Trading Range Analysis
30-Day Trading Range
$35.03 -
$44.12
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.72
(8.0%)
Support & Resistance Levels
Support Level
$40.99
Resistance Level
$49.00
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.81
Wall Street Target
$39.00
(-15.8%)
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
136.8%
Profit Margin
4.0%
Valuation Premium vs History
+6.3% premium
PE vs Historical
9.8 vs 8.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.3%
(market-implied from PE analysis)
1-Year Target
$49.22
(+6%)
2-Year Target
$52.32
(+13%)
3-Year Target
$55.61
(+20%)
3-Yr Target (if PE normalizes)
(PE: 10→8)
PE COMPRESSION
$46.50
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 8.7%)
$125.86
(+172%)
Base:
(SPY PE: 9.8, Growth: 8.7%)
$59.54
(+29%)
Bear:
(PE: 8.2, Growth: 8.7%)
$49.79
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 24.41 | Current EPS (TTM): $1.77
Bull Case
$95.06
(+105%)
Analyst growth 100.0%, PE expands to 26.9
Base Case
$86.42
(+87%)
Market implied 100.0%, PE stable at 24.4
Bear Case
$29.38
(-37%)
Severe decline -20.0%, PE contracts to 20.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 9:52 AM ET
Data refreshes hourly during market hours. Next update: 10:52 AM
Data refreshes hourly during market hours. Next update: 10:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
Advanced CNMD Option Strategies
Professional options setups generated by AI based on today's CNMD price and gamma walls.
